Literature DB >> 29185838

Cataract Surgery Complications in Uveitis Patients: A Review Article.

Stephanie M Llop1, George N Papaliodis1.   

Abstract

Uveitis is a leading causes of blindness worldwide, and the development of cataracts is common due to both the presence of intraocular inflammation and the most commonly employed treatment with corticosteroids. The management of these cataracts can be very challenging and often requires additional procedures that can compromise surgical results. The underlying disease affects a relatively young population at higher risk of complications. Preoperative control of inflammation/quiescent disease for at least three months is generally accepted as the minimum amount of time prior to surgical intervention. Phacoemulsification with intraocular lens is the preferred method for surgery, with some studies showing improvement in visual acuity in over 90% of patients. The most common postoperative complications include macular edema, posterior capsule opacification, recurrent or persistent inflammation, glaucoma, epiretinal membrane and IOL deposits, or dislocation. Despite the potential complications, cataract surgery in uveitis patients is considered a safe and successful procedure.

Entities:  

Keywords:  Cataracta complicata; cataract complications; cataract extraction; phacoemulsificationuveitis

Mesh:

Year:  2017        PMID: 29185838     DOI: 10.1080/08820538.2017.1353815

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  20 in total

1.  Cataract management in Ebola virus disease survivors: clinical and scientific implications.

Authors:  Alexa L Li; Duncan E Berry; Jessica G Shantha; Steven Yeh
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

Review 2.  Do we need day-1 postoperative follow-up after cataract surgery?

Authors:  Andrzej Grzybowski; Piotr Kanclerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-12-19       Impact factor: 3.117

Review 3.  [Pharmacological treatment strategies and surgical options for uveitis].

Authors:  Justus G Garweg
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

4.  Factors Predictive of Remission of Chronic Anterior Uveitis.

Authors:  Lucia Sobrin; Maxwell Pistilli; Kurt Dreger; Srishti Kothari; Naira Khachatryan; Pichaporn Artornsombudh; Siddharth S Pujari; C Stephen Foster; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; John H Kempen
Journal:  Ophthalmology       Date:  2019-11-28       Impact factor: 12.079

5.  Therapeutic potential of pupilloplasty combined with phacomulsification and intraocular lens implantation against uveitis-induced cataract.

Authors:  Hui Lu; Dou-Dou Chen; Si-Quan Zhu
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

6.  Clinical features of childhood uveitis at a tertiary referral center in Southern Turkey.

Authors:  Ebru Esen; Selcuk Sizmaz; Sibel Balci; Rabia Miray Kisla Ekinci; Nihal Demircan
Journal:  Int Ophthalmol       Date:  2021-02-24       Impact factor: 2.031

7.  Resident immune cells of the avascular lens: Mediators of the injury and fibrotic response of the lens.

Authors:  A Sue Menko; JodiRae DeDreu; Caitlin M Logan; Heather Paulson; Alex V Levin; Janice L Walker
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.834

Review 8.  Immune cells in lens injury repair and fibrosis.

Authors:  Janice L Walker; A Sue Menko
Journal:  Exp Eye Res       Date:  2021-06-11       Impact factor: 3.770

Review 9.  Immune responses to injury and their links to eye disease.

Authors:  Mary Ann Stepp; A Sue Menko
Journal:  Transl Res       Date:  2021-05-27       Impact factor: 10.171

10.  Surgical Outcomes of Contrast Sensitivity and Visual Acuity in Uveitis-Associated Cataract.

Authors:  Atsunobu Takeda; Eiichi Hasegawa; Shoji Notomi; Keijiro Ishikawa; Mitsuru Arima; Yusuke Murakami; Shintaro Nakao; Toshio Hisatomi; Koh-Hei Sonoda
Journal:  Clin Ophthalmol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.